Food News and Research

RSS

Auxilium and Prasco introduce authorized generic version of Testim

Auxilium Pharmaceuticals, Inc., a fully integrated specialty biopharmaceutical company, today announced that it has partnered with Prasco, LLC ("Prasco") to introduce an Authorized Generic version of Testim® (testosterone gel).

11 Jun 2014

New research collaboration aims to develop better therapies for autoimmune diseases

Seattle Children's Research Institute and biotechnology company Kineta, Inc. today launched the Alliance for Children's Therapeutics (ACT), a first-of-its-kind pediatric research and funding collaboration designed to speed development of new medications for children and teens with lupus nephritis and other autoimmune diseases like multiple sclerosis, Type 1 diabetes and rheumatoid arthritis.

11 Jun 2014

PSPA welcomes FDA’s new advice on fish consumption

The Pacific Seafood Processors Association (PSPA), a leading nonprofit seafood industry trade association, is thrilled to see new advice from the Food and Drug Administration (FDA) encouraging pregnant women and small children to eat more seafood.

11 Jun 2014

New device designed to detect foodborne bacteria

A new device designed to sample and detect foodborne bacteria is being trialled by scientists at the University of Southampton.

11 Jun 2014

Helix Healthcare Group offers individualized treatment for substance abuse, addiction, mental health issues

Helix Healthcare Group is the first integrated facility in Canada to offer a highly individualized approach in the treatment of substance abuse, addiction and mental health issues.

11 Jun 2014

Knowing summer allergies

As if a runny nose and red eyes weren't enough to ruin your warm weather look, summer allergies can gift you with even more than you've bargained for this year. In fact, some unusual symptoms can leave you looking like you lost a round in a boxing ring.

11 Jun 2014

Children's Hospital Los Angeles ranked among nation's top 5 again

For the third straight year, Children's Hospital Los Angeles is ranked among the top five children's hospitals in the country, a distinction that recognizes the hospital's clinical expertise and the quality and breadth of its patient care.

11 Jun 2014

Study presents oxytocin as latest treatment target for age-related muscle wasting

Researchers at the University of California, Berkeley, have discovered that oxytocin -- a hormone associated with maternal nurturing, social attachments, childbirth and sex -- is indispensable for healthy muscle maintenance and repair, and that in mice, it declines with age.

11 Jun 2014

Antimicrobial abrasion-resistant coatings with long-term effect for killing germs reliably

Researchers at the INM - Leibniz Institute for New Materials have now produced antimicrobial abrasion-resistant coatings with both silver and copper colloids with a long-term effect that kill germs reliably and at the same time prevent germs becoming established.

11 Jun 2014

Mayo Clinic receives two awards from Practice Greenhealth

Mayo Clinic was recently honored with two awards from Practice Greenhealth for its efforts in responsible environmental practices.

11 Jun 2014

FDA grants orphan drug designation to EffRx Pharmaceuticals' EX404 for treatment of PCOS

EffRx Pharmaceuticals SA, a specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration has granted orphan drug designation to its proprietary metformin-based product candidate, EX404, for the treatment of pediatric polycystic ovary syndrome (PCOS).

11 Jun 2014

Covidien receives FDA approval for Apollo Onyx delivery micro catheter

Covidien plc today announced U.S. Food and Drug Administration approval of its Apollo Onyx delivery micro catheter - the first detachable tip micro catheter available in the U.S.

11 Jun 2014

VuCOMP receives FDA approval for M-Vu CAD for mammography version 3.1

VuCOMP, Inc., leading developer of advanced computer vision systems for the detection of breast cancer, announced today that it has received U.S. Food and Drug Administration approval for M-Vu CAD for mammography version 3.1. Concurrently, VuCOMP is releasing an update to its CAD station which includes the ability to process additional standard screening views.

10 Jun 2014

AB SCIEX launches MasterView Food Testing Workflow for QTRAP mass spectrometry systems

AB SCIEX, a global leader in analytical technologies, today announced the launch of the MasterView™ Food Testing Workflow for QTRAP® mass spectrometry systems at the 5th Annual FERA/JIFSAN Symposium on Emerging Issues in Food, in York, UK.

10 Jun 2014

Auxogyn receives clearance from FDA for Eeva System

Auxogyn, Inc. a leader in women's reproductive health, today announced that its first product, the Eeva System, received clearance from the U.S. Food and Drug Administration through its de novo classification process, a regulatory pathway for select novel, low- to moderate-risk medical devices that are first-of-a-kind.

10 Jun 2014

$arGEN-X partner with LLS to develop ARGX-110 for patients with refractory WM$

arGEN-X partner with LLS to develop ARGX-110 for patients with refractory WM

arGEN-X, a clinical stage biopharmaceutical company focused on creating and developing differentiated therapeutic antibodies for the treatment of cancer and severe autoimmune diseases, today announced it has entered into a partnership with The Leukemia & Lymphoma Society (LLS) in which both parties will contribute to the funding of a Phase 2 clinical study of the Company's lead candidate, ARGX-110, in patients with refractory Waldenström's macroglobulinemia (WM).

10 Jun 2014

Celsion signs definitive asset purchase agreement to acquire EGEN

Celsion Corporation (Celsion) (NASDAQ: CLSN), an oncology drug development company, and EGEN, Inc. (EGEN), a privately-held biopharmaceutical company focused on the development of nucleic acid-based therapeutics for the treatment of cancer and other difficult to treat diseases, today announced the signing of a definitive asset purchase agreement in which Celsion will acquire substantially all of the assets of EGEN, including its Phase Ib DNA-based immunotherapy product candidate EGEN-001 and its therapeutic platform technologies, TheraPlas™ for delivery of DNA and mRNA, TheraSilence™ for delivery of RNA, and RAST™ for Cell Enabled Expression and Secretion of RNA.

10 Jun 2014

New therapeutic interventions could render addiction into manageable disease

Neuroscientists agree that abuse of drugs hijacks circuits in the brain that are crucial for decision-making, but society as a whole tends to stigmatize addicted people for lacking self-control.

10 Jun 2014

Exercise and diet impact on gut microbial diversity

Scientists at the Science Foundation Ireland-funded Alimentary Pharmabiotic Centre (APC) at University College Cork and Teagasc Food Research Centre, Moorepark, have carried out a study in conjunction with the Irish Rugby Football Union that has revealed that exercise and associated dietary changes influence gut microbial diversity.

10 Jun 2014

Viewpoints: 'Triage' at the VA; GOP can't 'fix' health law; mental health problems in LA jail

Washington's attention span on the Veterans Affairs scandal seems to be expiring. Though 42 of the VA's 152 major campuses (27%) are still under investigation for falsifying wait-time records, the Senate is converging on a bipartisan deal that claims to solve the problem.

10 Jun 2014